Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies
Wolfgang Jäger(University of Alberta), Peter C. Black(University of British Columbia)
Cited by 47
Related Papers
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective
|Nature Reviews Urology|2022|196
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†
|European Urology|2019|191
Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer
|European Urology|2019|183